Old Web
English
Sign In
Acemap
>
authorDetail
>
Ncctg
Ncctg
Medicine
Oncology
Internal medicine
Cancer
Pathology
4
Papers
232
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
HER2 positive breast cancer
2016
Rachel Dear Mbbs
Antonio C. Wolff
Trastuzumab Trastuzumab
Nsabp B
Ncctg
Show All
Source
Cite
Save
Citations (20)
NCCTG N0572 phase I/II trial of sorafenib and temsirolimus in patients with recurrent glioblastoma: A North Central Cancer Treatment Group study.
2011
Journal of Clinical Oncology
Kurt A. Jaeckle
David Schiff
S. K. Anderson
Evanthia Galanis
P. J. Stella
Patrick J. Flynn
Jann N. Sarkaria
Bernd W. Scheithauer
Bradley J. Erickson
Jan Craig Buckner
Ncctg
Show All
Source
Cite
Save
Citations (3)
Phase I evaluation of sorafenib (SOR) and bevacizumab (BEV) as first-line therapy in hepatocellular cancer (HCC): North Central Cancer Treatment Group trial N0745.
2011
Journal of Clinical Oncology
Joleen M Hubbard
Steven Robert Alberts
W. S. Loui
Michelle R. Mahoney
Lewis Rowland Roberts
Thomas Christopher Smyrk
Zoran Gatalica
Shaji Kumar
Shaker R. Dakhil
P. J. Flynn
Jacqueline M. Lafky
Martin J. Bury
Ncctg
Show All
Source
Cite
Save
Citations (3)
Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer
2007
Journal of Clinical Oncology
E. A. Perez
Edward H. Romond
Vera Jean Suman
Jong-Hyeon Jeong
Nancy E. Davidson
Charles E. Geyer
Silvana Martino
Eleftherios P. Mamounas
P. A. Kauffman
Norman Wolmark
Ncctg
Nsabp
Show All
Source
Cite
Save
Citations (206)
1